Drugs / Inactivated influenza split vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01511744 | Nov 2011 | influenza | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05297994 Comparator | Oct → Dec 2016 | influenza | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated influenza split vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05297994 ↗ |
| Modality | Vaccine | “Influenza vaccine (split virion), Inactivated” NCT01511744 ↗ |
| Route | Intramuscular | “solution for intramuscular injection” NCT05297994 ↗ |